Phoenix Biotechnology acquires the assets of Anvirlat, Inc.

Phoenix Biotechnology acquires the assets of Anvirlat, Inc., a Nevada corporation, conducting pharmaceutical research in Central America on the therapeutic effects of plant extracts for patients suffering from neoplastic disease.